|
| Press Releases |
|
 |
|
| Friday, March 21, 2025 |
|
|
China Medical System (00867) Released its 2024 Annual Results: Focusing on Innovation and Specialty Breakthroughs to Reshape Growth Momentum |
| On March 17, China Medical System Holdings Limited ("CMS" or the "Company") released its 2024 annual results. The Company recorded a turnover of RMB7,469 million, representing a year-on-year decrease of 6.8%; in the case that all medicines were directly sold by the Company, the turnover would be RMB8,622 million, representing a year-on-year decrease of 9.0%. more info >> |
|
| Friday, February 14, 2025 |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| more info >> |
|
|
China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025 |
| In February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited ("CMS" or the "Group") has been included in the S&P Global Sustainability Yearbook 2025 (the "Yearbook 2025"). more info >> |
|
| Friday, January 24, 2025 |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| more info >> |
|
|
China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 |
| China Medical System (00867) Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 more info >> |
|
| Thursday, January 9, 2025 |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
|
China Medical System (00867) Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer's Type |
| China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary of the Company entered into a License, Collaboration and Distribution Agreement (the "Agreement") with Alpha Cognition Inc. ("Alpha") of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets)("ZUNVEY" or the "Product") for the treatment of mild-to-moderate dementia of the Alzheimer's type. more info >> |
|
| Monday, December 9, 2024 |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China |
| China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China more info >> |
|
| Monday, December 2, 2024 |
|
|
China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia |
| China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Everest Medicines Announces Approval of 'B' Marker Removal from Company's Stock Code by the Hong Kong Stock Exchange
Apr 23, 2025 09:09 HKT/SGT
|
|
|
Earth Day Special: foundit Report Reveals 27% Surge in Green Jobs as Singapore Accelerates Sustainability Push
Apr 23, 2025 09:00 HKT/SGT
|
|
|
CIRC: Attained a New High in Fiscal Year 2024
Apr 23, 2025 08:57 HKT/SGT
|
|
|
2025 U.S. Open Polo Championship Final Concludes American High-Goal Season, Supported by U.S. Polo Assn.
Apr 22, 2025 22:41 HKT/SGT
|
|
|
2025年美國高水準馬球賽季圓滿落幕－美國馬球協會鼎力支持的U.S. Open馬球錦標賽總決賽
Apr 22, 2025 19:00 HKT/SGT
|
|
|
2025年美国高水平马球赛季圆满落幕——美国马球协会鼎力支持的U.S. Open马球锦标赛总决赛
Apr 22, 2025 19:00 HKT/SGT
|
|
|
A Strategic Event for HR Leaders and Experts to Drive Transformation in the Saudi Workforce
Apr 22, 2025 16:40 HKT/SGT
|
|
|
New Trading Bot Pivozon Targets Gold Traders Using Hourly Chart Strategies
Apr 22, 2025 16:00: JST
|
|
|
Under the patronage of Maktoum bin Mohammed DIFC to host 3rd edition of Dubai FinTech Summit on 12-13 May 2025
Apr 22, 2025 16:00 HKT/SGT
|
|
|
New Trading Bot Pivozon Targets Gold Traders Using Hourly Chart Strategies
Apr 22, 2025 15:30 HKT/SGT
|
|
|
Meerkat ($MERK) introduces utility-focused meme ecosystem with staking, gaming, and AI features
Apr 22, 2025 12:00: JST
|
|
|
A Decade of Olympus India's Commitment to Community Welfare
Apr 22, 2025 13:00 JST
|
|
|
Meerkat ($MERK) introduces utility-focused meme ecosystem with staking, gaming, and AI features
Apr 22, 2025 11:00 HKT/SGT
|
|
|
富士通と理研、世界最大級の256量子ビットの超伝導量子コンピュータを開発
Apr 22, 2025 11:00: JST
|
|
|
北京能源國際2024年業績：戰略韌性築基 創新效能引領綠色增長新範式
Apr 22, 2025 10:49 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
